Real-world Study of Pyrotinib in Neoadjuvant Therapy for HER2-positive Breast Cancer

NCT05561686 · clinicaltrials.gov ↗

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

HER2-positive Breast Cancer

Interventions

DRUG: Pyrotinib

Sponsor

Hunan Cancer Hospital

Collaborators

[object Object]